Investor profile
Landegren Gene Technology has backed 1 European tech company across 1 funding round in 2022, joining rounds totalling €8.5M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Navinci Diagnostics | Sweden | 1 | €8.5M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Navinci Diagnostics | Series A | €8.5M | 2022-07 |
